Prognostic factor in patient with recurrent pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factor in patient with recurrent pancreatic adenocarcinoma

Published:2023-09-02 Issue:1 Volume:408 Page:
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Sumiyoshi Tatsuaki,Uemura Kenichiro,Shintakuya Ryuta,Okada Kenjiro,Otsuka Hiroyuki,Baba Kenta,Serikawa Masahiro,Ishii Yasutaka,Tsuboi Tomofumi,Arihiro Koji,Murakami Yoshiaki,Murashita Jyunji,Takahashi Shinya

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00423-023-03073-2.pdf

Reference52 articles.

1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30

2. Uesaka K, Boku N, Fukutomi A et al (2016) Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 388:248–257

3. Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

4. Schorn S, Demir IE, Samm N, Scheufele F, Calavrezos L, Sargut M et al (2018) Meta-analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma. BJS Open 2:52–61

5. Seelen LWF, Floortje van Oosten A, Brada LJH, Groot VP, Daamen LA, Walma MS et al (2023) Early recurrence after resection of locally advanced pancreatic cancer following induction therapy: an international multicenter study. Ann Surg 278:118–126

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP